Literature DB >> 33121621

Novel Assays/Applications for Patients Suspected of Mycobacterial Diseases.

Niaz Banaei1, Kimberlee A Musser2, Max Salfinger3, Akos Somoskovi4, Adrian M Zelazny5.   

Abstract

Although tuberculosis is slowly decreasing, nontuberculous mycobacterial lung disease is significantly increasing. We describe new methods and applications for faster turnaround times in the diagnosis of tuberculosis and nontuberculous mycobacterial lung disease and have included the latest mycobacterial taxonomy. Although the focus is mainly on molecular assays, we also discuss improvements of acid-fast bacilli smear microscopy and stress the need for performing minimal inhibitory concentration determinations especially for tuberculosis. Additionally, important considerations for negative nucleic acid amplification assay results used for releasing tuberculosis suspects from airborne infection isolation rooms saving precious resources for the health care system, are also included.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MALDI-TOF mass spectrometry; Minimal inhibitory concentration; Molecular drug resistance; Mycobacterium tuberculosis; Nontuberculous mycobacteria; Nucleic acid amplification testing; Tuberculosis; Whole genome sequencing

Year:  2020        PMID: 33121621     DOI: 10.1016/j.cll.2020.08.010

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  1 in total

1.  Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics?

Authors:  Sagal Mohamed; Claudio U Köser; Max Salfinger; Wladimir Sougakoff; Scott K Heysell
Journal:  Eur Respir J       Date:  2021-03-18       Impact factor: 16.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.